IP Library › Granted Patent US 10,064,813
Granted Patent B2
US 10,064,813 · App. 14/963,886 · Granted Sep 4, 2018

Cosmetic compositions

Inventors: Tiffany Florence (Addison, TX); Michelle Hines (Addison, TX); David Gan (Addison, TX)
Assignee: Mary Kay Inc.
A61K8/97A61K8/064A61K8/11A61K8/20A61K8/34A61K8/342A61K8/345A61K8/347A61K8/37A61K8/375A61K8/41A61K8/42A61K8/43A61K8/60A61K8/64A61K8/70A61K8/73A61K8/733A61Q17/04A61Q19/007A61Q19/008A61Q19/02A61Q19/08A61Q19/10A61K2800/522A61K2800/596A61K2800/70A61K2800/78A61K2800/782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,064,813
App. No.
14/963,886
Granted
Sep 4, 2018
Kind
B2
Abstract

Disclosed are compositions and methods for their use that can be used in cosmetic applications. The composition can include an effective amount of a Centella asiatica stem cells to reduce the activity of hyaluronidase in skin, an effective amount of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate or Alpinia galanga leaf extract to promote the production of hyaluronic acid in skin, an effective amount of tripeptide-1 to promote the production of fibronectin and laminin in skin, and a dermatologically acceptable vehicle.

Claims (39)

1. A method for treating skin, the method comprising topically applying a composition to skin in need of treatment, wherein the composition comprises:

0.0001-0.3 wt. % of a Centella asiatica meristem cell culture to reduce the activity of hyaluronidase in skin;

0.0001 to 1% by weight of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate or 0.0001 to 1% by weight Alpinia galanga leaf extract to promote the production of hyaluronic acid in skin;

0.00001 to 1% by weight of tripeptide-1 to promote the production of fibronectin and laminin in skin;

retinol;

Punica granatum extract or sterols thereof;

Codium tomentosum extract;

Cinnamomum Cassia bark extract;

Glycyrrhiza glabra (Licorice) root extract; and

a dermatologically acceptable vehicle,

wherein topical application of the composition reduces the activity of hyaluronidase in skin, increases the production of hyaluronic acid in skin, and increases the production of fibronectin and laminin in skin.

2. The method of claim 1 , wherein the composition includes an effective amount of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate to promote the production of hyaluronic acid in skin.

3. The method of claim 1 , wherein the composition includes an effective amount of Alpinia galanga leaf extract to promote the production of hyaluronic acid in skin.

4. The method of claim 1 , wherein the composition further comprises glycerin and xanthan gum.

5. The method of claim 4 , wherein the composition comprises tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate and further comprises magnesium chloride, and water.

6. The method of claim 4 , wherein the composition comprises Alpinia galanga leaf extract and further comprises water, butylene glycol, and caprylic/capric triglyceride.

7. The method of claim 5 , wherein the composition further comprises urea, glucose, and guanidine HCL.

8. The method of claim 6 , wherein the composition further comprises urea, glucose, and guanidine HCL.

9. The method of claim 1 , wherein the composition is formulated as a serum, cream, or cleanser.

10. The method of claim 1 , wherein the composition is applied to a fine line or wrinkle.

11. The method of claim 1 , wherein the composition is applied to sagging skin or non-elastic skin.

12. The method of claim 1 , wherein the composition is applied to the periorbital region of skin.

13. The method of claim 1 , wherein the composition is applied to facial skin or neck skin.

14. The method of claim 1 , wherein after topical application the composition remains on the skin for at least 30 minutes.

15. The method of claim 1 , wherein the composition further comprises adenosine.

16. The method of claim 1 , wherein the dermatologically acceptable vehicle comprises:

water;

glycerin;

Butyrospermum parkii (shea) butter;

glyceryl stearate;

caprylic/capric triglyceride;

isocetyl stearate;

butylene glycol;

phenoxyethanol;

PEG-100 stearate;

dimethicone;

triethanolamine;

disodium EDTA; and

carbomer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2015
From: FLORENCE, TIFFANY; HINES, MICHELLE; GAN, DAVID
To: MARY KAY INC.
Reel/Frame 037250/0504 →
Continuity (5)
Continuation 13468874 · May 10, 2012
Provisional Application 61550813 · Oct 24, 2011
Provisional Application 61495208 · Jun 9, 2011
Provisional Application 61484542 · May 10, 2011
Related Publication 20160095814A1 · Apr 7, 2016